8 months ago
Clinical Laboratory Industry 2023 - 2030 |
The global clinical laboratory markets combine to account for USD 321.20 billion in revenue in 2022, which is expected to reach USD 493.72 billion by 2030, growing at a cumulative rate of 5.52% over the forecast period. The combination bundle is designed to provide a holistic view of these highly dynamic market spaces.
Download Sample Copy@ https://cutt.ly/uw0dJysJ
Competitive Landscape
Competitive rivalry in this market is to be high due to a large number of service providers, increasing number of contract research organizations, and high R&D investment to develop novel tests for different healthcare applications. These players have adopted strategies such as acquisitions, and collaborations to strengthen their product portfolio offered for clinical laboratory tests. Moreover, global players are expanding their services in developing countries due to high medical unmet needs and collaborating with local players in developing economies.
Some of the key players in the clinical laboratory market include Abbott, ARUP Laboratories, OPKO Health, Inc., Bioscientia Healthcare GmbH, Charles River Laboratories, NeoGenomics Laboratories, Healthscope, Labco, Laboratory Corporation of America Holdings, Fresenius Medical Care AG & Co. KGaA, QIAGEN, Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Tulip Diagnostics (P) Ltd, Sonic Healthcare Limited, Merck KGaA, Biosino Bio-Technology and Science Inc., Cinven, DaVita Inc., SGS Société Générale de Surveillance SA, and Almac Group
#ClinicalLabAdvancements #PrecisionDiagnostics #FutureOfHealthcare #LabIndustryInnovation #PersonalizedMedicine #AdvancedTesting #NextGenLabServices #DiagnosticRevolution #PatientCareExcellence #LabIndustryGrowth
The global clinical laboratory markets combine to account for USD 321.20 billion in revenue in 2022, which is expected to reach USD 493.72 billion by 2030, growing at a cumulative rate of 5.52% over the forecast period. The combination bundle is designed to provide a holistic view of these highly dynamic market spaces.
Download Sample Copy@ https://cutt.ly/uw0dJysJ
Competitive Landscape
Competitive rivalry in this market is to be high due to a large number of service providers, increasing number of contract research organizations, and high R&D investment to develop novel tests for different healthcare applications. These players have adopted strategies such as acquisitions, and collaborations to strengthen their product portfolio offered for clinical laboratory tests. Moreover, global players are expanding their services in developing countries due to high medical unmet needs and collaborating with local players in developing economies.
Some of the key players in the clinical laboratory market include Abbott, ARUP Laboratories, OPKO Health, Inc., Bioscientia Healthcare GmbH, Charles River Laboratories, NeoGenomics Laboratories, Healthscope, Labco, Laboratory Corporation of America Holdings, Fresenius Medical Care AG & Co. KGaA, QIAGEN, Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Tulip Diagnostics (P) Ltd, Sonic Healthcare Limited, Merck KGaA, Biosino Bio-Technology and Science Inc., Cinven, DaVita Inc., SGS Société Générale de Surveillance SA, and Almac Group
#ClinicalLabAdvancements #PrecisionDiagnostics #FutureOfHealthcare #LabIndustryInnovation #PersonalizedMedicine #AdvancedTesting #NextGenLabServices #DiagnosticRevolution #PatientCareExcellence #LabIndustryGrowth
